Shelley M Herbrich

8PUBLICATIONS
37CO-AUTHORS
Innate immunityFood properties (incl. characteristics and health benefits)Molecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 09, 2026
Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade.

Mehdi Chaib, Muhammad Aminu, Shelley Herbrich

|Nov 11, 2025
Microbiota and vitamin A flux shape intestinal T cells.

Shelley Herbrich, Padmanee Sharma

|Sep 10, 2025
Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti-PD-1 therapy.

Jielin Liu, Shelley Herbrich, Sreyashi Basu

|Mar 19, 2025
ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis.

Shelley Herbrich, Mehdi Chaib, Padmanee Sharma

|Apr 23, 2022
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy.

Sankaranarayan Kannan, Mary E Irwin, Shelley M Herbrich

Pageof 2